Promptly was selected to the phase 1 of the ProEmpower, a European Project that aims to empower patients with type 2 diabetes in managing their own disease.
Promptly is a member of the winning consortium - Gnomon Informatics
ProEmpower is a pre–commercial procurement (PCP) project to buy R&D services to improve the treatment and self-management of diabetes type 2 patients using a Personalised Diabetes Management Solution.
In total, 15 tenders were submitted, and after an evaluation process five tenders were selected to continue to Phase 1 of the project
ProEmpower receives funding from the European Union’s Horizon 2020 research and innovation programme and it is structured in three phases:
Related Link: Learn more about ProEmpower project